False-positive EMIT II opiates from ofloxacin

Therapeutic Drug Monitoring

Volumn 19, Issue 1, 1997, Pages 98-99

  Meatherall, R ^a   Dai, J ^a  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Cross reactivity; Drug testing; EMIT; Ofloxacin

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; OPIATE AGONIST;

ARTICLE; AUTOANALYZER; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ERROR; DRUG DETERMINATION; DRUG MONITORING; DRUG URINE LEVEL; HUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; ANTIBODIES; CIPROFLOXACIN; CROSS REACTIONS; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FALSE POSITIVE REACTIONS; HUMANS; MORPHINE; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN;

EID: 0031410315     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199702000-00019     Document Type: Article

References (4)

1. Monk JP, Campoli-Richards DM. Ofloxacin, a review of its antibacterial activity. Drugs 1987;33:346-91.
2. MacGowon AP, Greig MA, Clarke EA, White LO, Reeves DS. The pharmacokinetics of norfloxacin in the aged. J Antimicrob Chemother 1988;22:721-7.
3. Hoffken G, Lode H, Pinzing C, Borner K, Koeppe P. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother 1985;27:375-9.
4. Paul BD, Mell LD, Mitchell JM, Irving J, Novak A. Simultaneous identification and quantitation of codeine and morphine in urine by capillary gas chromatography and mass spectrometry. J Anal Toxicol 1985;9:222-6.